EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer
Advanced Science · 2026
DOI: 10.1002/advs.202504238 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Chengyu Lv und 8 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzho…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Cell Nucleolus, Eukaryotic Initiation Factor-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fujian Provincial Natural Science Foundation of China, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Endometrial cancer harboring TP53 aberrations presents a significant therapeutic challenge due to the lack of druggable targets. A promising strategy involves inducing senescence in cancer cells followed by targeted elimination using senolytic agents. The preliminary findings indicated that the aberrant subcellular localization of EIF1AX in endometrial cancer is significantly correlated with a poor prognosis. In this study, a compound library is employed to screen for therapeutic agents that induce the nuclear localization of EIF1AX in endometrial cancer cells, followed by a CRISPR library screen to identify senolytic compounds. The results demonstrated that the combination of 2,5‐MeC and dacinostat effectively inhibited tumor growth. Mechanistically, co‐immunoprecipitation mass spectrometry and cleavage under targets and tagmentation sequencing analyses demonstrated that 2,5‐MeC acts as a potent inducer of EIF1AX nucleolar translocation. This translocation promoted senescence by recruiting DDX21 to form nucleolar aggregates, which suppressed rDNA transcription. Additionally, RNA sequencing and antibody array analyses revealed that the synthetic lethality of 2,5‐MeC and dacinostat is mediated through the activation of the JNK/MAPK signaling pathway. Collectively, these findings highlight a novel therapeutic strategy for TP53‐aberrant endometrial cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350001, P. R. China.
- Key Laboratory of Stem Cell Engineering and Regenerative Medicine of Fujian Province University, Fujian Medical University, Fuzhou, 350122, P. R. China.
- Department of Histology and Embryology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, 350122, P. R. China.
- Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fujian Medical University, Fuzhou, 350005, P. R. China.
ORCID-Profile: Chengyu Lv, Zihang Lin, Jiandong Sun, Pengming Sun, Shie Wang
Förderung
- National Natural Science Foundation of China
- Fujian Provincial Natural Science Foundation of China
- Fujian Provincial Health Technology Project
- Fujian Maternity and Child Health Hospital Foundation
- Science and Technology Innovation Foundation of Fujian Province
- Scientific Research Project of National Key Clinical Specialty Construction Project
- Startup Fund for Scientific Research of Fujian Medical University
Zitieren
APA
Lv, C., Lin, Z., Sun, J., Ye, Y., Wu, Q., Cai, L., Liu, D., Sun, P., & Wang, S. (2026). EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer. Advanced Science. https://doi.org/10.1002/advs.202504238
Vancouver
Lv C, Lin Z, Sun J, Ye Y, Wu Q, Cai L, et al. EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer. Advanced Science. 2026. doi:10.1002/advs.202504238
BibTeX
@article{Lv2026,
author = {Lv, Chengyu and Lin, Zihang and Sun, Jiandong and Ye, Yuhong and Wu, Qibin and Cai, Liangzhi and Liu, Dabin and Sun, Pengming and Wang, Shie},
title = {EIF1AX Nucleolar Condensates Enhance Susceptibilities for the Management of Endometrial Cancer},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202504238}
}
EUVIMED